this invention describes the application of selected polymers as novel drug delivery systems which use the body temperature and ph to induce a liquid to gel transition of the polymer which contains a drug or therapeutic agent therein . the goal of such a delivery system is to achieve a greater degree of bioavailability or sustained concentration of a drug .